Division of Infectious Diseases and Program in Global Health, David Geffen School of Medicine at the University of California, Los Angeles, California, United States of America.
PLoS One. 2009 Sep 25;4(9):e7201. doi: 10.1371/journal.pone.0007201.
Syndromic management is an inexpensive and effective method for the treatment of symptomatic sexually transmitted infections (STIs), but its effectiveness as a method of STI control in at-risk populations is questionable. We sought to determine the potential utility of syndromic management as a public health strategy to control STI transmission in high-risk populations in urban Peru.
We surveyed 3,285 at-risk men and women from three Peruvian cities from 2003-05. Participants were asked about the presence of genital ulcers, discharge, or dysuria in the preceding six months. Participants reporting symptoms were asked about subsequent health-seeking and partner notification behavior. Urine and vaginal swab samples were tested for Neisseria gonorrhoeae and Chlamydia trachomatis by nucleic acid testing. Serum was tested for syphilis and Herpes Simplex Virus-Type 2 antibodies.
Recent urogenital discharge or dysuria was reported by 42.1% of participants with gonorrhea or chlamydia versus 28.3% of participants without infection. Genital ulceration was reported by 6.2% of participants with, and 7.4% of participants without, recent syphilis. Many participants reporting symptoms continued sexual activity while symptomatic, and approximately half of all symptomatic participants sought treatment. The positive and negative predictive values of urogenital discharge or genital ulcer disease in detecting STIs that are common in the study population were 14.4% and 81.5% for chlamydia in women and 8.3% and 89.5% for syphilis among gay-identified men.
In our study, STIs among high-risk men and women in urban Peru were frequently asymptomatic and symptomatic participants often remained sexually active without seeking treatment. Additional research is needed to assess the costs and benefits of targeted, laboratory-based STI screening as part of a comprehensive STI control program in developing countries.
症状性管理是一种廉价且有效的治疗有症状性性传播感染(STI)的方法,但作为高危人群 STI 控制方法的有效性存在疑问。我们旨在确定症状性管理作为控制秘鲁城市高危人群 STI 传播的公共卫生策略的潜在效用。
我们于 2003-05 年在秘鲁三个城市调查了 3285 名高危男性和女性。参与者被问及在过去六个月中是否存在生殖器溃疡、分泌物或尿痛。报告有症状的参与者被问及随后的求医和伴侣通知行为。通过核酸检测检测尿液和阴道拭子样本中的淋病奈瑟菌和沙眼衣原体。检测血清中的梅毒和单纯疱疹病毒 2 型抗体。
最近有淋病或衣原体感染者中,42.1%报告有泌尿生殖道分泌物或尿痛,而无感染者中为 28.3%。最近患有梅毒的参与者中有 6.2%报告有生殖器溃疡,而无感染者中为 7.4%。许多报告有症状的参与者在有症状时仍继续进行性行为,大约一半的有症状参与者寻求治疗。在检测本研究人群中常见的 STI 时,泌尿生殖道分泌物或生殖器溃疡疾病对衣原体的阳性和阴性预测值分别为女性中的 14.4%和 81.5%,男同性恋者中的梅毒分别为 8.3%和 89.5%。
在我们的研究中,秘鲁城市高危男性和女性中的 STI 经常无症状,有症状的参与者经常在没有寻求治疗的情况下继续进行性行为。需要进一步研究来评估针对高危人群的基于实验室的 STI 筛查的成本效益,作为发展中国家综合 STI 控制计划的一部分。